E. Ishai

A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

E. Feige, I. Mendel, E. Breitbart, 2010, Journal of Neuroimmunology.

Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats

A. Volkov, B. Feldman, I. Mendel, 2018, Basic & clinical pharmacology & toxicology.

Identification of Motile Sperm Domain–Containing Protein 2 as Regulator of Human Monocyte Migration

I. Mendel, N. Yacov, E. Breitbart, 2017, The Journal of Immunology.

Reactions of trimethylsilyl-derived iodohydrins with electron-rich π-systemsElectronic supplementary information (ESI) available: Additional results and experimental data, 1H NMR, 13C NMR and mass spectral data. See http://www.rsc.org/suppdata/p1/b1/b105233k/

B. Feit, E. Ishai, S. Shamai, 2002 .

Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis

I. Mendel, N. Yacov, E. Breitbart, 2016, Digestive Diseases and Sciences.

VB‐201, an oxidized phospholipid small molecule, inhibits CD14‐ and Toll‐like receptor‐2‐dependent innate cell activation and constrains atherosclerosis

J. George, D. Harats, E. Feige, 2014, Clinical and experimental immunology.